Join to View Full Profile
12605 E 16th AveAurora, CO 80045
Phone+1 720-848-0000
Dr. Nagel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am an Associate Professor in Neurology at the University of Colorado School of Medicine in Aurora, CO, fellowship trained in Neurovirology. In my clinical practice, I see general neurology patients, as well as those with complications from neurotropic viruses, including varicella zoster virus (VZV) and herpes simplex virus-1/2 (HSV-1, HSV-2). My NIH-funded laboratory focuses on pathological cerebrovascular remodeling due to VZV infection of arteries, manifesting clinically as aneurysms and hemorrhagic/ischemic stroke; characterization of other forms of VZV vasculopathy, including Giant Cell Arteritis and Takayasu's Arteritis, and; the role of HSV-1/2 reactivation in atypical facial pain, burning mouth syndrome, and chronic headaches.
Use the following link to get PDF versions of my articles:
http://www.ucdenver.edu/academics/colleges/medicalschool/departments/neurology/Faculty/Documents/MD_CV%202015/CV_Nagel%20MASTER_04.09.15.pdf
Education & Training
University of ColoradoResidency, Neurology, 2003 - 2006- University of ColoradoInternship, Internal Medicine, 2002 - 2003
University of Illinois College of MedicineClass of 2002
Certifications & Licensure
CO State Medical License 2006 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Olfactory and trigeminal routes of HSV-1 CNS infection with regional microglial heterogeneity.Christy S Niemeyer, Laetitia Merle, Andrew N Bubak, B Dnate' Baxter, Arianna Gentile Polese
Journal of Virology. 2024-11-19 - 1 citationsSuppression of the host antiviral response by non-infectious varicella zoster virus extracellular vesicles.Christy S Niemeyer, Seth Frietze, Christina Coughlan, Serena W R Lewis, Sara Bustos Lopez
Journal of Virology. 2024-08-20 - Diagnostic value of anti-VZV IgG in neurological diseases among varicella unvaccinated individuals.Ilakkiya Arumugam, Sivacchandran Subbarayan Rajasekaran, Krithika Gopalakrishnan, Sivasubramaniyan Gnanaskandan, Seetha N Jeganathan
Journal of Neurovirology. 2024-06-01
Journal Articles
- Varicella Zoster Virus Productively Infects Human Peripheral Blood Mononuclear Cells to Modulate Expression of Immunoinhibitory Proteins and Blocking PD-L1 Enhances Vi...David M Koelle, Maria A Nagel, PLoS One
- Reactivation of Simian Varicella Virus (SVV) in Rhesus Macaques After CD4 T Cell DepletionMaria Nagel, MD, mBio
Other
- Varicella Zoster Virus VasculopathyMaria Nagel, MD, The Journal of Infectious Diseases
https://www.doximity.com/articles/5621df86-6458-49c6-83a1-5fac314f1827
UpToDate, Wolters Kluwer Health - 2012-12-12
Press Mentions
The Vaccine That Can Dramatically Reduce Your Risk of DementiaApril 3rd, 2025- Shingles Is Awful, but Here’s Another Reason to Get Vaccinated: It May Fight DementiaApril 2nd, 2025
- Shingles Vaccine May Cut Risk of Dementia, Study SaysApril 2nd, 2025
- Join now to see all
Grant Support
- Purinergic Signaling in Varicella Zoster Virus VasculopathyNational Institute of Neurological Disease and Stroke2015–2019
- The Molecular Pathogenesis of Varicella Zoster Virus InfectionNational Institute of Aging2014–2019
- Mechanisms By Which VZV IE Proteins Interact With Cell Antiviral Proteins To PrevNational Institute Of Neurological Disorders And Stroke2009–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
